This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Mereo Biopharma 1 Limited. Active years: 2020-2023.
Company Filing History:
Years Active: 2020-2023
Certainly! Here is an article about the innovative inventor Jacqueline Parkin:
Title: Innovation in COPD Treatment by Inventor Jacqueline Parkin
Introduction:
Jacqueline Parkin, a talented inventor based in London, GB, has made significant contributions to the field of healthcare with her groundbreaking patents in the treatment of chronic obstructive pulmonary disease (COPD).
Latest Patents:
Jacqueline Parkin's latest patents showcase her expertise in utilizing 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide for the treatment and prevention of acute exacerbations of COPD in patients with specific blood eosinophil levels. Her innovative pharmaceutical compositions offer promising solutions for managing this complex respiratory condition.
Career Highlights:
With a total of 5 patents to her name, Jacqueline Parkin has demonstrated a commitment to advancing healthcare through her inventive approach to COPD management. Her dedication to improving patient outcomes in this challenging area is truly commendable.
Collaborations:
Jacqueline Parkin collaborates with esteemed colleagues in her work at Mereo Biopharma 1 Limited. Alongside coworkers like Colin Orford and Cyril Clarke, she continues to drive innovation and excellence in the development of novel treatments for respiratory diseases.
Conclusion:
In conclusion, Jacqueline Parkin's pioneering work in the field of COPD treatment serves as a beacon of hope for patients and healthcare professionals alike. Her inventive spirit and collaborative efforts at Mereo Biopharma 1 Limited are shaping the future of respiratory healthcare.